Worth Seeing!
Best Stocks from Nifty 500 View list Now View list Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 74616.48
5.37 (0.01%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
31
Natco Pharma Ltd.
18,108
(Small Cap)
1,037.35
(2.61%)
14.17
3.29
4.38
0.36
Q V PT
32
Concord Biotech Ltd.
17,344
(Small Cap)
1,655.05
(-0.17%)
72.24
12.14
0.00
0.00
Q V PT
33
Aster DM Healthcare Ltd.
17,153
(Small Cap)
349.50
(1.78%)
52.93
3.74
12.17
15.37
Q V PT
34
Suven Pharmaceuticals Ltd.
17,043
(Small Cap)
661.45
(-1.20%)
45.95
8.6
0.00
0.00
Q V PT
35
Krishna Institute of Medical Sciences Ltd
15,902
(Small Cap)
2,000.80
(0.69%)
60.73
8.74
12.50
0.00
Q V PT
36
Poly Medicure Ltd.
15,738
(Small Cap)
1,667
(1.66%)
65.94
11.35
16.00
20.25
Q V+ PT
37
Rainbow Childrens Medicare Ltd.
14,071
(Small Cap)
1,418.90
(2.36%)
63.95
11.45
22.62
38.74
Q V PT
38
Astrazeneca Pharma India Ltd.
13,335
(Small Cap)
5,359
(0.47%)
95.73
19.88
11.93
36.87
Q V+ PT
39
Eris Lifesciences Ltd.
12,120
(Small Cap)
897.65
(0.76%)
31.36
4.82
14.52
6.67
Q V PT
40
Jubilant Pharmova Ltd.
10,768
(Small Cap)
683.30
(1.07%)
N/A
4.61
-24.52
-28.13
Q V+ PT
41
Granules India Ltd.
10,299
(Small Cap)
424.20
(-0.18%)
22.2
3.42
19.01
31.51
Q V PT
42
Caplin Point Laboratories Ltd.
10,109
(Small Cap)
1,323.75
(-0.55%)
23.1
4.61
22.13
21.09
Q V PT
43
Neuland Laboratories Ltd.
9,829
(Small Cap)
7,537.70
(-1.61%)
31.06
8.14
17.70
56.85
Q V+ PT
44
Metropolis Healthcare Ltd.
9,265
(Small Cap)
1,801.20
(-0.40%)
74.26
8.63
12.15
6.00
Q V PT
45
Wockhardt Ltd.
8,737
(Small Cap)
566.10
(-0.61%)
N/A
2.48
-7.60
0.00
Q V PT
46
Strides Pharma Science Ltd.
8,253
(Small Cap)
885.50
(-1.39%)
111.2
2.34
4.76
-151.49
Q V PT
47
Procter & Gamble Health Ltd.
7,985
(Small Cap)
4,727.70
(-1.71%)
35.23
9.91
11.99
36.80
Q V PT
48
Jupiter Life Line Hospitals Ltd.
7,908
(Small Cap)
1,223.95
(1.48%)
73.76
6.57
19.71
26.72
Q V PT
49
Sun Pharma Advanced Research Company Ltd.
7,706
(Small Cap)
231.95
(-2.32%)
N/A
33.21
24.99
0.00
Q V+ PT
50
Marksans Pharma Ltd.
7,593
(Small Cap)
166.50
(-0.63%)
64.03
6.39
17.33
59.01
Q V PT
51
FDC Ltd.
7,271
(Small Cap)
452.20
(1.25%)
24.55
3.55
10.84
3.42
Q V+ PT
52
Vijaya Diagnostic Centre Ltd.
6,913
(Small Cap)
673.20
(-0.34%)
61.25
11.09
0.00
0.00
Q V PT
53
Blue Jet Healthcare Ltd.
6,604
(Small Cap)
382.20
(0.39%)
41.27
4.02
0.00
0.00
Q V PT
54
Shilpa Medicare Ltd.
5,417
(Small Cap)
545
(-1.61%)
N/A
2.37
5.89
-183.46
Q V PT
55
Healthcare Global Enterprises Ltd.
4,936
(Small Cap)
360
(1.58%)
123.72
4.16
11.39
7.94
Q V PT
56
Aarti Pharmalabs Ltd.
4,636
(Small Cap)
513.15
(0.32%)
26.1
2.94
0.00
0.00
Q V+ PT
57
Aarti Drugs Ltd.
4,597
(Small Cap)
498.10
(-0.39%)
25.51
3.69
16.91
15.52
Q V PT
58
AMI Organics Ltd.
4,480
(Small Cap)
1,215.10
(0.04%)
115.57
6.98
26.79
33.72
Q V PT
59
Kovai Medical Center & Hospital Ltd.
4,443
(Small Cap)
4,070
(0.23%)
28.1
5.33
11.48
15.15
Q V+ PT
60
Advanced Enzyme Technologies Ltd.
4,423
(Small Cap)
391.60
(-0.99%)
36.11
7.69
8.00
9.23
Q V PT
2

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Ajanta Pharma
2,428.608.75%
Piramal Pharma
153.507.27%
Solara Active Pharma
551.753.54%
Torrent Pharma
2,7673.49%
Alembic Pharma
1,021.102.80%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Bliss GVS Pharma
121.15-6.23%
NGL Fine-Chem
2,543.85-3.44%
SMS Pharmaceuticals
200-2.68%
Medicamen Biotech
544.35-2.62%
Sun Pharma Adv. Res
231.95-2.32%
View More

News about Top Pharma Companies in India

Ami Organics informs about board meeting

Ami Organics has informed that meeting of the Board of Directors of the Company is scheduled to be held on May 10, 2024, to consider the recommendation of final dividend for the FY 2023-24 as per the details attached.

The above information is a part of company’s filings submitted to BSE.

02 May, 2024

AMI Organics informs about board meeting

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AMI Organics has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 10, 2024 at the Registered Office of the Company, to transact the following matters: 1. To consider and approve the Audited Standalone & Consolidated Financial Statements and Results of the Company for the quarter and year ended March 31, 2024. 2. To consider the recommendation of Final Dividend for the F.Y. 2023-24 to equity shareholders of Company, subject to the approval by members in the ensuing Annual General Meeting. 3. Other business matters. The Board Meeting shall be preceded by Audit Committee Meeting on the same day. Further pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with our intimation letter dated March 28, 2024 it was informed that the Trading Window for dealing in shares of the Company by designated persons, shall remain closed from April 1, 2024 until 48 hours after the declaration of financial results by the Company for the fourth quarter and year ended March 31, 2024. Accordingly, the trading window shall remain closed until Sunday, May 12, 2024 and shall reopen on the next day.

The above information is a part of company’s filings submitted to BSE.

02 May, 2024

Krishna Institute of Medical Sciences informs about board meeting

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that a meeting of the Board of Directors of the company is scheduled to be held on Thursday, May 16, 2024 to consider and approve the audited (Standalone & Consolidated) financial results of the company for the quarter and financial year ended March 31, 2024. Further, in accordance with the Company’s Code of Conduct for the Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from Monday i.e., April 01 2024 till the expiry of 48 hours from the date the said financial results are made public.

The above information is a part of company’s filings submitted to BSE.

02 May, 2024

Metropolis Healthcare informs about disclosure

Pursuant to Regulation 30 of the Listing Regulations and in continuation to itsletter dated August 14, 2023, Metropolis Healthcare has informed that the suit filed by Metropolis Bramser Lab Services (Mtius) (‘Metropolis Bramser’, step-down WOS of the Company) before the Supreme Court of Mauritius has been dismissed. The details as required under SEBI Circular No SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13 July 2023 are enclosed.

The above information is a part of company’s filings submitted to BSE.
30 Apr, 2024

Granules India informs about press release

Granules India has informed that it enclosed the press release titled ‘Granules India Limited Announced ANDA Approval for Colchicine Capsules’.

The above information is a part of company’s filings submitted to BSE.

30 Apr, 2024

Granules India gains as its arm gets USFDA’s approval for Colchicine Capsules

Granules now have a total of 64 ANDA approvals from the USFDA
30 Apr, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sun Pharmaceutical Industries Ltd. 3,64,315 Crore
2 Cipla Ltd. 1,14,614 Crore
3 Divis Laboratories Ltd. 1,05,233 Crore
4 Dr. Reddys Laboratories Ltd. 1,04,900 Crore
5 Zydus Lifesciences Ltd. 99,426 Crore
6 Mankind Pharma Ltd. 93,499 Crore
7 Torrent Pharmaceuticals Ltd. 90,494 Crore
8 Apollo Hospitals Enterprise Ltd. 85,638 Crore
9 Max Healthcare Institute Ltd. 79,221 Crore
10 Lupin Ltd. 75,096 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,603 19,989 33.14 21.10 22.53 51.69
Abbott India Ltd. (M) Very Good 26,691 56,532 49.35 16.53 33.68 31.69
Laurus Labs Ltd. (S) Very Good 450.5 24,237 151.0 5.90 33.09 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 6,323 1,04,900 20.06 3.90 12.15 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,767 90,494 60.57 12.66 29.05 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,677 75,096 132.6
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 1,061 29,926 95.07
Zydus Lifesciences Ltd. (L) Very Good 981.0 99,426 91.34
Ipca Laboratories Ltd. (M) Very Good 1,353 34,260 90.69
Aurobindo Pharma Ltd. (M) Very Good 1,160 67,609 86.62
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 450.5 24,237 151.0 5.90 33.09 24.05
Granules India Ltd. (S) Somewhat Good 424.2 10,299 22.20 3.42 13.42 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,894 29,276 57.84 10.41 34.16 18.11
Gland Pharma Ltd. (M) Very Good 1,710 28,345 35.38 3.27 20.11 17.42
Mankind Pharma Ltd. (L) Very Good 2,325 93,499 56.66 10.21 39.13 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 450.5 24,237 151.0 5.90 33.09 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 6,323 1,04,900 20.06 3.90 12.15 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,894 29,276 57.84 10.41 34.16 31.92
Biocon Ltd. (M) Somewhat Good 306.9 37,345 19.49 3.43 100.5 31.80
Granules India Ltd. (S) Somewhat Good 424.2 10,299 22.20 3.42 13.42 31.51
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.